Skip to main content

Table 4 Relationships between dose-volume-histogram parameters and the incidence of grade 2 or higher late radiation pneumonitis

From: Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia

 

Grade ≤ 1

Grade ≥ 2

P value

Pneumonitis (N = 25)

Pneumonitis (N = 4)

Median

IQR

Median

IQR

Lung-GTV

     

MLD (GyRBE)

7.0

(3.4–11.2)

10.8

(8.2–12.9)

0.36

V5GyRBE (%)

21.8

(11.1–28.0)

26.7

(19.0–32.7)

0.44

V10GyRBE (%)

18.6

(8.8–25.7)

24.7

(17.7–29.9)

0.44

V20GyRBE (%)

13.7

(6.4–19.6)

20.2

(15.1–24.3)

0.37

  1. IQR interquartile range, GTV gross tumor volume, MLD mean lung dose, RBE relative biological effectiveness, V5GyRBE, V10GyRBE, V20GyRBE, and V40GyRBEvolume receiving a dose of ≥ 5/10/20/40 GyRBE